Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection

Background. Vancomycin-resistant Enterococcus (VRE) is a major healthcare-associated pathogen and a well known complication among transplant and immunocompromised patients. We report on stool VRE clearance in a post hoc analysis of the Phase 2 PUNCH CD study assessing a microbiota-based drug for rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubberke, Erik R., Mullane, Kathleen M., Gerding, Dale N., Lee, Christine H., Louie, Thomas J., Guthertz, Harriet, Jones, Courtney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047394/
https://www.ncbi.nlm.nih.gov/pubmed/27703995
http://dx.doi.org/10.1093/ofid/ofw133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047394/
https://www.ncbi.nlm.nih.gov/pubmed/27703995
http://dx.doi.org/10.1093/ofid/ofw133

Ejemplares similares